Press release
04.10.2024 To the attention of interested persons EMA starts safety review of medicines containing finasteride and dutasteride download document …
Press release
20.09.2024 To the attention of interested persons EMA recommends measures to minimise serious outcomes of known side effect with painkiller […]
Press release
06.09.2024 To the attention of interested persons EMA recommends measures to minimise serious outcomes of known side effect with painkiller […]
Important notification
19.08.2024 To the attention of all importers, distributors and users of medical devices The NAMMDR warns all importers and distributors […]
Important notification
13.08.2024 To the attention of professional users who work or are employed in healthcare facilities The European Commission is currently […]
Important notification
08.08.2024 To the attention of all importers, distributors and users of medical devices The NAMMDR warns all importers and distributors […]
Press release
26.07.2024 To the attention of interested persons EMA advises about risks of using weight loss medicine Mysimba with opioids download […]
Press release
24.07.2024 To the attention of interested persons EMA confirms its recommendation to update the antigenic composition of authorised COVID-19 vaccines […]
Important notification
17.07.2024 To the attention of interested persons Announcement regarding professional training and instruction courses for staff with specific duties of […]
Press release
12.07.2024 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 July 2024 download […]